Lv1
50 积分 2024-08-26 加入
NTR 2.0: a rationally engineered prodrug-converting enzyme with substantially enhanced efficacy for targeted cell ablation
10小时前
已完结
Discovery of Highly Selective CYP1B1 Inhibitors
19天前
已完结
The expanding repertoire of covalent warheads for drug discovery
1个月前
已完结
RIPTACs: A groundbreaking approach to drug discovery
1个月前
已完结
Design of a Lead-Like Cysteine-Targeting Covalent Library and the Identification of Hits to Cys55 of Bfl-1
1个月前
已完结
Structural Chemistry of Helicase Inhibition
4个月前
已完结
Discovery of N-Trifluoromethylated Noscapines as Novel and Potent Agents for the Treatment of Glioblastoma
6个月前
已完结
Discovery of First Branched-Chain Ketoacid Dehydrogenase Kinase (BDK) Inhibitor Clinical Candidate PF-07328948
6个月前
已完结
Gliocidin is a nicotinamide-mimetic prodrug that targets glioblastoma
6个月前
已完结
A comprehensive review of recent developments in the gram-negative bacterial UDP-2,3-diacylglucosamine hydrolase (LpxH) enzyme
8个月前
已完结
皖公网安备34019202002308
